Title : Overview of CDK9 as a target in cancer research.

Pub. Date : 2016

PMID : 26766294






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical studies of the drugs flavopiridol, dinaciclib, seliciclib, SNS-032 and RGB-286638 used as CDK9 inhibitors are also reviewed, with their additional targets and their relative IC50 values. dinaciclib cyclin dependent kinase 9 Homo sapiens